Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program
December 19, 2024 09:00 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
Artios Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024 08:00 ET
|
Artios Pharma
CAMBRIDGE, United Kingdom and NEW YORK, December 19, 2024 – Artios Pharma Limited (“Artios”), a clinical-stage biotech company led by pioneers of DNA damage response (“DDR”) drug development, today...
KFSHRC Successfully Performs Robotic-Assisted Retroperitoneal Lymph Node Dissection
December 18, 2024 13:03 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Successfully Performs Robotic-Assisted Retroperitoneal Lymph Node Dissection
The Wistar Institute Receives Two Biomedical Research Grants from the V Foundation for Cancer Research
December 16, 2024 11:03 ET
|
The Wistar Institute
PHILADELPHIA, PA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Wistar Institute assistant professors Nan Zhang, Ph.D., and Noam Auslander Ph.D., have both received independent funding totaling $1.2 million...
AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates
December 09, 2024 10:01 ET
|
American Academy of PAs
ALEXANDRIA, Va., Dec. 09, 2024 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) is proud to announce a new project, made possible through a grant from Exact Sciences, that...
Kaposi Sarcoma Strategic Research Report 2024: Global Market to Surpass $200 Million by 2030 as Emerging Markets Present New Opportunities
December 03, 2024 05:14 ET
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Kaposi Sarcoma - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Kaposi Sarcoma was...
Saladax Biomedical Inc. Welcomes Dr. Sepideh Fanaei as Country Manager for DACH Region, Supporting EU Expansion and Revenue Growth
November 21, 2024 10:00 ET
|
Saladax Biomedical, Inc.
Bethlehem, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. is thrilled to announce the appointment of Dr. Sepideh Fanaei as Country Manager for the DACH region, which encompasses...
Saladax Biomedical Inc. Welcomes Dr. Sepideh Fanaei as Country Manager for DACH Region, Supporting EU Expansion and Revenue Growth
November 21, 2024 04:00 ET
|
Saladax Biomedical, Inc.
Bethlehem, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. is thrilled to announce the appointment of Dr. Sepideh Fanaei as Country Manager for the DACH region, which encompasses...
10 year 8 Major Market Bladder Cancer Epidemiology Forecasts 2023-2033
November 18, 2024 10:20 ET
|
Research and Markets
Dublin, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The "Bladder Cancer: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.Bladder cancer (International Classification...
Shuttle Pharma Provides Third Quarter 2024 Corporate Update
November 13, 2024 17:00 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty...